Name: Inflammatory Diseases and Copper: The Metabolic and Therapeutic Roles of Copper and Other Essential Metalloelements in Humans (en Inglés)
Price: 226010.00 CLP
Availability: InStock
Author: Sorenson, John R. J.
ISBN: 9781461258315

portada Inflammatory Diseases and Copper: The Metabolic and Therapeutic Roles of Copper and Other Essential Metalloelements in Humans (en Inglés)

Inflammatory Diseases and Copper: The Metabolic and Therapeutic Roles of Copper and Other Essential Metalloelements in Humans (en Inglés)

Formato

Libro Físico

Autor

John R. J. Sorenson

Editorial

Humana

Idioma

Inglés

N° páginas

622

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 3.3 cm

Peso

0.89 kg.

ISBN13

9781461258315

Categorías

Enfermedades y trastornos
Bioquímica
Jardinería

Inflammatory Diseases and Copper: The Metabolic and Therapeutic Roles of Copper and Other Essential Metalloelements in Humans (en Inglés)

John R. J. Sorenson (Autor) · Humana · Tapa Blanda

Libro Nuevo Importado

Envío: 12 a 17 días háb.

$ 376.680$ 226.010

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 226.010

Llega entre el 03 Ago y el 10 Ago a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Inflammatory Diseases and Copper: The Metabolic and Therapeutic Roles of Copper and Other Essential Metalloelements in Humans (en Inglés)"

In 1928, it was discovered that copper was essential for normal human metabolism. A decade later, in 1938, it was observed that patients with rheu- matoid arthritis exhibited a higher than normal serum copper concentration that returned to normal with remission of this disease. Thirteen years later, it was found that copper complexes were effective in treating arthritic dis- eases. The first report that copper complexes had antiinflammatory activity in an animal model of inflammation appeared twenty-two years after the dis- covery of essentiality. In 1976, it was suggested that the active forms of the antiarthritic drugs are their copper complexes formed in vivo. This sugges- tion has been confirmed and extended in the interim in over 200 recent publications. Individual biomedical scientists from many countries who have published in these areas recently saw a need for a meeting to exchange current re- supporting new hypotheses. We search results and discuss the evidence met on the University of Arkansas Medical Sciences campus in Little Rock, Arkansas, August 10-13, 1981. Participants came from Australia, England, France, Germany, Israel, Italy, The Netherlands, Norway, Poland, Scotland, Sweden, Switzerland, Wales, Zimbabwe, and over twenty of the United States.